Overview

Effects of Montelukast in Asthmatic Children With and Without Food Allergy

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
- To search the effects of montelukast on the airway inflammation including FEV1%, FEV1%/FVC, the provocholine® (methacoline chloride powder for inhalation) challenge tests, the leukotriene levels in the exhaled breath condensate in asthmatic children with and without food allergy aged 6-18 years old. - To define the patient groups with good response to montelukast and to define the parameters which predict the good response.
Phase:
Phase 4
Details
Lead Sponsor:
Hacettepe University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast